Aim (Advanced Imaging Modality)
Payments companies reported to CMS as associated with Aim (Advanced Imaging Modality). "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Aim (Advanced Imaging Modality), per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Aim (Advanced Imaging Modality)
These are the largest totals companies reported as associated with Aim (Advanced Imaging Modality). They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Marina Kurian | New York, NY | Surgery | $5,500.00 |
| Joseph Greene | Reston, VA | Surgery | $3,240.00 |
| Philip Woodworth | Lone Tree, CO | Surgery | $2,700.00 |
| Ryan Broderick | San Diego, CA | Surgery | $1,600.00 |
| Benjamin Zendejas-Mummert | Boston, MA | Pediatric Surgery | $1,500.00 |
| Matthew Albert | Altamonte Springs, FL | Colon & Rectal Surgery | $1,000.00 |
| Matthew Carlson | Rochester, MN | Otolaryngology | $1,000.00 |
| Siba Haykal | New Haven, CT | Plastic Surgery | $608.55 |
| Adrian Park | Hagerstown, MD | Surgery | $434.37 |
| Jeremy Parcells | Mansfield, TX | Surgery | $319.49 |
Prescribed Aim (Advanced Imaging Modality)?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.